[Alternatives for adopting policies centered on access to medicines].
Latin America is adopting regulations that bear on medicinal costs and spending. The regulations have four main goals: i) to guarantee a competitive market, ii) to ensure affordability for individual consumers (commercial channel), iii) to contain public spending on medicines (institutional channel), and iv) to guarantee efficient spending on medicines. The experience of Latin America differs from that of countries in developed regions. In the latter, the countries tend to have similar policies, both in promoting generic medicines and in price control strategies, and in optimizing and containing pharmaceutical expense. In contrast, in Latin America, certain institutional weaknesses impede the consolidation and application of an effective regulatory policy. This paper reviews the experience gained through the adoption of economic regulations aimed at reducing spending and improving access to medicines, suggests lessons learned at the international level, and offers recommendations for the countries of Latin America. Its purpose is to offer key elements to decision-makers and the authorities of the countries concerned in pursuing economic regulation of medicines.
Universidad de Buenos Aires (UBA), Buenos Aires, Argentina.
Federico
F
Tobar
Ignacio
I
Drake
Evangelina
E
Martich
D017408:Guidelines as Topic; D006291:Health Policy; D006801:Humans; D007843:Latin America; D007880:Legislation, Drug; D004364:Pharmaceutical Preparations / Q000191:economics* / Q000600:supply & distribution*
D004364:Pharmaceutical Preparations